...
首页> 外文期刊>Journal of the American Chemical Society >PDGFR-β Promoter Forms a Vacancy G-Quadruplex that Can Be Filled in by dGMP: Solution Structure and Molecular Recognition of Guanine Metabolites and Drugs
【24h】

PDGFR-β Promoter Forms a Vacancy G-Quadruplex that Can Be Filled in by dGMP: Solution Structure and Molecular Recognition of Guanine Metabolites and Drugs

机译:PDGFR-β启动子形成可以由dGMP填充的空位G-四链体:鸟嘌呤代谢产物和药物的溶液结构和分子识别

获取原文
获取原文并翻译 | 示例
           

摘要

Aberrant expression of PDGFR-β is associated with a number of diseases. The G-quadruplexes (G4s) formed in PDGFR-β gene promoter are transcriptional modulators and amenable to small molecule targeting. The major G4 formed in the PDGFR-β gene promoter was previously shown to have a broken G-strand. Herein, we report that the PDGFR-β gene promoter sequence forms a vacancy G-quadruplex (vG4) which can be filled in and stabilized by physiologically relevant guanine metabolites, such as dGMP, GMP, and cGMP, as well as guanine-derivative drugs. We determined the NMR structure of the dGMP-fill-in PDGFR-β vG4 in K~+ solution. This is the first structure of a guanine-metabolite-fill-in vG4 based on a human gene promoter sequence. Our structure and systematic analysis elucidate the contributions of Hoogsten hydrogen bonds, sugar, and phosphate moieties to the specific G-vacancy fill-in. Intriguingly, an equilibrium of 3'- and 5'-end vG4s is present in the PDGFR-β promoter sequence, and dGMP favors the 5'-end fill-in. Guanine metabolites and drugs were tested and showed a conserved selectivity for the 5'-vacancy, except for cGMP. cGMP binds both the 3'- and 5'-end vG4s and forms two fill-in G4s with similar population. Significantly, guanine metabolites are involved in many physiological and pathological processes in human cells; thus, our results provide a structural basis to understand their potential regulatory functions by interaction with promoter vG4s. Moreover, the NMR structure can guide rational design of ligands that target the PDGFR-β vG4.
机译:PDGFR-β的异常表达与多种疾病有关。在PDGFR-β基因启动子中形成的G-四链体(G4)是转录调节剂,适合小分子靶向。先前显示在PDGFR-β基因启动子中形成的主要G4具有断裂的G链。在此,我们报道PDGFR-β基因启动子序列形成空缺的G-四链体(vG4),其可以被生理相关的鸟嘌呤代谢物如dGMP,GMP和cGMP以及鸟嘌呤衍生药物填充并稳定。 。我们确定了在K〜+溶液中dGMP填充的PDGFR-βvG4的NMR结构。这是基于人类基因启动子序列的鸟嘌呤代谢物填充vG4的第一个结构。我们的结构和系统分析阐明了Hoogsten氢键,糖和磷酸盐部分对特定G空位填充的贡献。有趣的是,PDGFR-β启动子序列中存在3'-端和5'-端vG4的平衡,而dGMP支持5'-端的填充。对鸟嘌呤代谢物和药物进行了测试,并显示了对5'空位的保守选择性,但cGMP除外。 cGMP结合3'和5'末端vG4,并形成两个具有相似种群的填充G4。重要的是,鸟嘌呤代谢物参与了人类细胞的许多生理和病理过程。因此,我们的结果为通过与启动子vG4s相互作用了解其潜在的调节功能提供了结构基础。此外,NMR结构可以指导针对PDGFR-βvG4的配体的合理设计。

著录项

  • 来源
    《Journal of the American Chemical Society》 |2020年第11期|5204-5211|共8页
  • 作者单位

    Department of Medicinal Chemistry and Molecular Pharmacology College of Pharmacy Purdue University West Lafayette Indiana 47907 United States;

    Department of Medicinal Chemistry and Molecular Pharmacology College of Pharmacy Purdue Center for Cancer Research and Purdue Institute for Drug Discovery Purdue University West Lafayette Indiana 47907 United States;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号